Funding Opportunities and Notices

NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents. Scroll down for information and opportunities that may be of interest. Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts   January 28, 2022 General Notices Notice of Technical Assistance Webinar for RFA-AR-22-009, HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (NOT-AR-22-016) National Institute of Arthritis and Musculoskeletal and Skin Diseases National Center for Complementary and Integrative Health National Institute on Aging National Institute of Dental and Craniofacial Research National Institute of Neurological Disorders and Stroke Notice of Participation of the National Institute of Dental and Craniofacial Research (NIDCR) in RFA-MD-22-004 Innovations for Healthy LivingImproving Minority Health and Eliminating Health Disparities (R43/R44- Clinical Trial Optional) (NOT-DE-22-004) National Institute of Dental and Craniofacial Research NIDDK Encourages Research on Sex/Gender Differences, Sexual and Gender Minority-Related Research and Race/Ethnic Diversity (NOT-DK-22-003) National Institute of Diabetes and Digestive and Kidney Diseases RESCINDED - Request for Information (RFI) on Advancing Research in Fundamental Neuroscience (NOT-NS-22-068) National Institute of Neurological Disorders and Stroke Request for Information (RFI) on Advancing Research in Fundamental Neuroscience (NOT-NS-22-073) National Institute of Neurological Disorders and Stroke Request for Public Comments on DRAFT Supplemental Information to the NIH Policy for Data Management and Sharing: Responsible Management and Sharing of American Indian/ Alaska Native Participant Data (NOT-OD-22-064) Office of the Director, NIH Notices of Changes to Funding Opportunities Notice of NIAAA's Participation in RFA-DA-22-047, "HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional)" (NOT-AA-22-008) National Institute on Alcohol Abuse and Alcoholism Notice of NIAAA's Participation in RFA-DA-22-048, "HEAL Initiative: Pilot & Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional)" (NOT-AA-22-009) National Institute on Alcohol Abuse and Alcoholism Notice of Correction to Award Project Period Information for PAS-19-316, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) (NOT-AG-22-011) National Institute on Aging National Institute of Neurological Disorders and Stroke Notice of Correction to Award Project Period Information for PAS-19-317, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) (NOT-AG-22-012) National Institute on Aging National Institute of Neurological Disorders and Stroke NEI Notice of Participation in PAR-20-310, "Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)" (NOT-EY-22-005) National Eye Institute NEI Notice of Participation in PAR-21-081, "Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)" (NOT-EY-22-006) National Eye Institute NEI Notice of Participation in PAR-22-072, "Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)" (NOT-EY-22-007) National Eye Institute Notice of Change to Application Types Allowed for RFA-MH-22-120, "Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional)" (NOT-MH-22-150) National Institute of Mental Health Notice to Extend the Expiration Date for PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)" (NOT-OD-22-066) National Institutes of Health Notices of Intent to Publish Notice of Intent to Publish a Funding Opportunity Announcement for Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional) (NOT-CA-22-041) National Cancer Institute Notice of Intent to Publish a Funding Opportunity Announcement for Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) (NOT-CA-22-042) National Cancer Institute Notice of Intent to Publish a Funding Opportunity Announcement for Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (NOT-CA-22-043) National Cancer Institute Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) (NOT-NS-22-070) National Institute of Neurological Disorders and Stroke Notices of Special Interest Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research (NOT-CA-22-037) National Cancer Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Drug Abuse National Institute of Mental Health National Institute of Nursing Research Office of Behavioral and Social Sciences Research Notice of Special Interest (NOSI): Discovery of the Genetic Basis of Conditions Associated with Down Syndrome for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (X01) (NOT-OD-22-058) Office of the Director, NIH National Heart, Lung, and Blood Institute Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact (NOT-OD-22-069) Office of the Director, NIH National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Eye Institute National Human Genome Research Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Library of Medicine Funding Opportunities Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) (PAR-22-078) National Institutes of Health National Center for Complementary and Integrative Health National Cancer Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Neurological Disorders and Stroke National Library of Medicine Application Receipt Date(s): June 24, 2022 Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) (RFA-HL-23-010) National Heart, Lung, and Blood Institute Application Receipt Date(s): Multiple dates, see announcement. Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) (RFA-HL-23-011) National Heart, Lung, and Blood Institute Application Receipt Date(s): Multiple dates, see announcement. Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) (RFA-HL-23-012) National Heart, Lung, and Blood Institute Application Receipt Date(s): Multiple dates, see announcement. Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) (RFA-HL-23-013) National Heart, Lung, and Blood Institute Application Receipt Date(s): Multiple dates, see announcement. Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) (RFA-HL-23-014) National Heart, Lung, and Blood Institute Application Receipt Date(s): December 20, 2024 BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) (RFA-MH-22-115) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 07, 2024 NIMH Instrumentation Program (S10 Clinical Trial Not Allowed) (RFA-MH-22-155) National Institute of Mental Health Application Receipt Date(s): Multiple dates, see announcement. Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) (RFA-NR-22-001) National Institute of Nursing Research National Institute on Drug Abuse National Institute of Mental Health National Institute on Minority Health and Health Disparities Office of Behavioral and Social Sciences Research Office of Disease Prevention Application Receipt Date(s): April 07, 2022 Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required) (RFA-NR-22-002) National Institute of Nursing Research Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Minority Health and Health Disparities Office of Research on Women's Health Application Receipt Date(s): April 07, 2022 Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional) (RFA-NR-22-003) National Institute of Nursing Research Eunice Kennedy Shriver National Institute of Child Health and Human Development Office of Research on Women's Health Application Receipt Date(s): April 07, 2022 NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format - click here for details. To UnSubscribe to the NIH Guide Weekly TOC LISTSERV, follow the instructions here. This weekly list can be found here. To join or leave the NIBIB Listserv, please visit this webpage and complete the online form. You can also change your options for the Listserv at this site.

HOME  |  DISCLAIMER  |  POLICIES  |  ACCESSIBILITY  |  FOIA  |  NEWS  |  CONTACT US

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute for Biomedical Imaging and Bioengineering · 9000 Rockville Pike, Building 31, Room 1C14, Bethesda, MD 20892